Johnson & Johnson starts phase three trial testing of COVID-19 vaccine candidate

Dan Barouch: "Covid-19 Vaccine Development" (12/1/21)Подробнее

J&J chief scientist on phase 3 trial for coronavirus vaccineПодробнее

Johnson & Johnson pauses COVID-19 vaccine trial due to 'unexplained illness'Подробнее

COVID-19 VACCINESПодробнее

Johnson & Johnson starts phase three trial testing of COVID-19 vaccine candidateПодробнее

Johnson & Johnson starts phase 3 coronavirus vaccine trialПодробнее

Why do experts have high hopes in Johnson & Johnson COVID-19 vaccine?Подробнее

Jim Cramer on Johnson & Johnson entering phase 3 trial for coronavirus vaccineПодробнее

COVID-19 Immune Response and Vaccine CandidatesПодробнее

Dr. Dan Barouch: COVID-19 Vaccine DevelopmentПодробнее

J&J - Bio E aims to manufacture 400mn doses of Covid vaccine in a year: Paul StoffelsПодробнее

COVID-19: IMMUNE RESPONSE & VACCINE CANDIDATESПодробнее

J&J chief scientific officer on Covid-19 vaccine trials in U.S., BelgiumПодробнее

Coronavirus vaccine: Pfizer starts phase 3 trial, stock leaps after earnings beat expectationsПодробнее

Ask Dr. Nandi: Moderna plans to start phase 3 testing of its COVID-19 vaccine candidate in JulyПодробнее